Hypoxia-induced CTCF mediates alternative splicing via coupling chromatin looping and RNA Pol II pause to promote EMT in breast cancer
Cell Reports · 2025-02 · 44 (2) · 115267
DOI: 10.1016/j.celrep.2025.115267 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025-02. Verfasst von Parik Kakani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Indian Institute of Science Education and Research Bhopal, Bhopal, Madhya Pradesh 462066, India. Hauptthemen laut MEDLINE: CCCTC-Binding Factor, Epithelial-Mesenchymal Transition, Alternative Splicing, Breast Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: India Ministry of Science & Technology Department of Biotechnology, Science and Engineering Research Board, University Grants Commission.
Abstract (Originalsprache)
Hypoxia influences the epithelial-mesenchymal transition (EMT) through the remodeling of the chromatin structure, epigenetics, and alternative splicing. Hypoxia drives CCCTC-binding factor (CTCF) induction through hypoxia-inducible factor 1-alpha (HIF1α), which promotes EMT, although the underlying mechanisms remain unclear. We find that hypoxia significantly increases CTCF occupancy at various EMT-related genes. We present a CTCF-mediated intricate mechanism promoting EMT wherein CTCF binding at the collagen type V alpha 1 chain (COL5A1) promoter is crucial for COL5A1 upregulation under hypoxia. Additionally, hypoxia drives exon64A inclusion in a mutually exclusive alternative splicing event of COL5A1exon64 (exon64A/64B). Notably, CTCF mediates COL5A1 promoter-alternatively spliced exon upstream looping that regulates DNA demethylation at distal exon64A. This further regulates the CTCF-mediated RNA polymerase II pause at COL5A1exon64A, leading to its inclusion in promoting the EMT under hypoxia. Genome-wide study indicates the association of gained CTCF occupancy with the alternative splicing of many cancer-related genes, similar to the proposed model. Specifically, disrupting the HIF1α-CTCF-COL5A1exon64A axis through the dCas9-DNMT3A system alleviates the EMT in hypoxic cancer cells and may represent a novel therapeutic target in breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Indian Institute of Science Education and Research Bhopal, Bhopal, Madhya Pradesh 462066, India.
- National Center for Biological Sciences, Tata Institute for Fundamental Research, Bangalore, Karnataka 560065, India.
- Department of Biological Sciences, Indian Institute of Science Education and Research Bhopal, Bhopal, Madhya Pradesh 462066, India. Electronic address: sanjeevs@iiserb.ac.in.
Förderung
- India Ministry of Science & Technology Department of Biotechnology
- Science and Engineering Research Board
- University Grants Commission
- Department of Science and Technology, Ministry of Science and Technology, India
- Indian Institute of Science Education and Research Bhopal
Zitieren
APA
Kakani, P., Dhamdhere, S. G., Pant, D., Joshi, R., Mishra, S., Pandey, A., Notani, D., & Shukla, S. (2025). Hypoxia-induced CTCF mediates alternative splicing via coupling chromatin looping and RNA Pol II pause to promote EMT in breast cancer. Cell Reports, 44(2), 115267. https://doi.org/10.1016/j.celrep.2025.115267
Vancouver
Kakani P, Dhamdhere SG, Pant D, Joshi R, Mishra S, Pandey A, et al. Hypoxia-induced CTCF mediates alternative splicing via coupling chromatin looping and RNA Pol II pause to promote EMT in breast cancer. Cell Reports. 2025;44(2):115267. doi:10.1016/j.celrep.2025.115267
BibTeX
@article{Kakani2025,
author = {Kakani, Parik and Dhamdhere, Shruti Ganesh and Pant, Deepak and Joshi, Rushikesh and Mishra, Sachin and Pandey, Anchala and Notani, Dimple and Shukla, Sanjeev},
title = {Hypoxia-induced CTCF mediates alternative splicing via coupling chromatin looping and RNA Pol II pause to promote EMT in breast cancer},
journal = {Cell Reports},
year = {2025},
volume = {44},
number = {2},
pages = {115267},
doi = {10.1016/j.celrep.2025.115267}
}
EUVIMED